← Open Payments lookup

PHILIP SALTIEL: Open Payments

NPI 1710972948 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,006 in 102 payments from 18 companies in 2025. Trend: 2023 $2,110 · 2024 $2,362 · 2025 $2,006

Food & beverage: $2,006
CompanyPaymentsAmount
Lundbeck LLC20$332
Axsome Therapeutics, Inc.13$224
Bausch Health US, LLC9$223
ABBVIE INC.9$212
E.R. Squibb & Sons, L.L.C.7$166
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$102
Takeda Pharmaceuticals U.S.A., Inc.5$89
Otsuka America Pharmaceutical, Inc.5$87
Janssen Pharmaceuticals, Inc4$82
Teva Pharmaceuticals USA, Inc.4$81

Products named: REXULTI, VRAYLAR, COBENFY, WELLBUTRIN, ABILIFY ASIMTUFII, Auvelity, CAPLYTA, TRINTELLIX.

Industry payments across NY — which companies pay providers there.